RT Journal Article
SR Electronic
T1 Identifying Contextual and Spatial Risk Factors for Post-Acute Sequelae of SARS-CoV-2 Infection: An EHR-based Cohort Study from the RECOVER Program
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.13.22281010
DO 10.1101/2022.10.13.22281010
A1 Zhang, Yongkang
A1 Hu, Hui
A1 Fokaidis, Vasilios
A1 Lewis V, Colby
A1 Xu, Jie
A1 Zang, Chengxi
A1 Xu, Zhenxing
A1 Wang, Fei
A1 Koropsak, Michael
A1 Bian, Jiang
A1 Hall, Jaclyn
A1 Rothman, Russell L.
A1 Shenkman, Elizabeth A.
A1 Wei, Wei-Qi
A1 Weiner, Mark G.
A1 Carton, Thomas W.
A1 Kaushal, Rainu
YR 2022
UL http://medrxiv.org/content/early/2022/10/13/2022.10.13.22281010.abstract
AB Post-acute sequelae of SARS-CoV-2 infection (PASC) affects a wide range of organ systems among a large proportion of patients with SARS-CoV-2 infection. Although studies have identified a broad set of patient-level risk factors for PASC, little is known about the contextual and spatial risk factors for PASC. Using electronic health data of patients with COVID-19 from two large clinical research networks in New York City and Florida, we identified contextual and spatial risk factors from nearly 200 environmental characteristics for 23 PASC symptoms and conditions of eight organ systems. We conducted a two-phase environment-wide association study. In Phase 1, we ran a mixed effects logistic regression with 5-digit ZIP Code tabulation area (ZCTA5) random intercepts for each PASC outcome and each contextual and spatial factor, adjusting for a comprehensive set of patient-level confounders. In Phase 2, we ran a mixed effects logistic regression for each PASC outcome including all significant (false positive discovery adjusted p-value < 0.05) contextual and spatial characteristics identified from Phase I and adjusting for confounders. We identified air toxicants (e.g., methyl methacrylate), criteria air pollutants (e.g., sulfur dioxide), particulate matter (PM2.5) compositions (e.g., ammonium), neighborhood deprivation, and built environment (e.g., food access) that were associated with increased risk of PASC conditions related to nervous, respiratory, blood, circulatory, endocrine, and other organ systems. Specific contextual and spatial risk factors for each PASC condition and symptom were different across New York City area and Florida. Future research is warranted to extend the analyses to other regions and examine more granular contextual and spatial characteristics to inform public health efforts to help patients recover from SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the National Institutes of Health (NIH) Agreement OTA HL161847-01 (contract number EHR-01-21) as part of the Researching COVID to Enhance Recovery (RECOVER) research program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Weill Cornell Medicine and University of Florida gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.PASCpost-acute sequelae of SARS-CoV-2 infectionCOVID-19the 2019 novel coronavirus diseaseUSthe United StatesZCTA55-digit ZIP Code tabulation areaCRNclinical research network; PCORnet, the National Patient-Centered Clinical Research NetworkPM2.5fine particulate matter with diameters that are 2.5 μm and smallerCOcarbon monoxideSO2sulfur dioxideNO2nitrogen dioxidesulfate; ammonium;-, nitrateOMorganic matterBCblack carbonDUSTmineral dustSSsea-saltO3ozoneACAGThe University of Washington at St. Louis Atmospheric Composition Analysis GroupCACESThe Center for Air, Climate, & Energy SolutionsUS EPAThe United States Environmental Protection AgencyJHU CSSEJohns Hopkins University, Center for Systems Science and Engineering Coronavirus Resource CenterCDCThe Centers for Disease Control and PreventionNATANational Air Toxics AssessmentUSDAUS Department of AgricultureHUDDepartment of Housing and Urban DevelopmentUSPSUS Postal ServiceNACISThe North American Industry Classification SystemNDVINormalized Difference Vegetation IndexNDINeighborhood Deprivation IndexEDemergency departmentVIFvariance inflation factor.